In 2017 the Carnegie Academy for Science Education (CASE) was selected to manage the Amgen Biotech Experience (ABE) site in Washington, D.C., called ABE-DC. The Amgen Foundation has now awarded CASE an additional three years of funding. ABE-DC established an extensive professional development program and a rigorous biotechnology curriculum, including research-grade laboratory equipment loaned to D.C. high school teachers to implement real-world biotechnology labs in their classrooms. During the COVID-19 pandemic, CASE’s ABE-DC programming has pivoted to a virtual curriculum.
This fall corresponds to the start of the second grant cycle of CASE’s Amgen Foundation